Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07784179
NA

Ultrasound and Photoacoustic Imaging of Hydrocephalus in Pediatric Patients

Sponsor: Michael McDowell

View on ClinicalTrials.gov

Summary

The goal of this study is to out find out the capabilities and limitations of the combined photoacoustic and ultrasound (PAUS) imaging device for diagnosing hydrocephalus in children. The main questions it aims to answer are: * can PAUS imaging allow for new and better ways to rapidly diagnose hydrocephalus? * Can PAUS imaging be used to confirm that treatments for hydrocephalus are working? PAUS imaging has been FDA approved for other medical conditions, but this is the first study to evaluate it for hydrocephalus detection. Participants will undergo imaging through the anterior fontanelle with the dual-mode PAUS imaging device. Each imaging session will take about 30 to 60 minutes. These sessions will take place once before and once after hydrocephalus treatment, as the participant is willing. In some cases, if a patient is having cerebrospinal fluid removed at the bedside, an additional imaging session will occur to monitor the procedure in real-time, if the participant is willing.

Official title: Ultrasound and Photoacoustic Imaging of Hydrocephalus

Key Details

Gender

All

Age Range

0 Days - 3 Years

Study Type

INTERVENTIONAL

Enrollment

250

Start Date

2026-09

Completion Date

2029-09

Last Updated

2026-08-25

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

PAUS imaging

PAUS imaging will be conducted before and after hydrocephalus treatment procedures and, if applicable, during cerebrospinal removal procedures at the bedside.